Literature DB >> 7499858

Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase.

Z Mĕlková1, M Esteban.   

Abstract

Nitric oxide (NO) exerts multiple biologic roles in animal cells through differential regulation of three distinct forms of NO synthase encoded by separate genes. Macrophage-inducible nitric oxide synthase (iNOS) has been correlated with inhibition of viral growth, but little is known about the mechanism of this effect. To study the antiviral role of NO, we have generated a vaccinia virus (VV) recombinant expressing iNOS under the control of Escherichia coli LacI operator/repressor elements. When cultured cells of various origins are infected with this recombinant virus, there is inducible expression of iNOS in the presence of isopropylthio-beta-galactoside, as determined by Western blot and by detection of nitrite, a NO oxidation product. The levels of nitrite increase with time after infection, correlating with marked inhibition of VV DNA and late protein synthesis. Expression of VV early proteins is not affected by NO. Inhibition of VV DNA synthesis is likely to be in part a consequence of NO-mediated inhibition of viral ribonucleotide reductase, as this inhibition can be partially overcome by addition of deoxyribonucleosides. Inhibition of the essential viral functions by NO results in a reduction of virus yields by 50 to 90%, depending on the cell line. Thus, our results demonstrate a direct antiviral effect of NO, with inhibition of VV replication occurring at the level of DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499858

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Nitric oxide inhibition of coxsackievirus replication in vitro.

Authors:  C Zaragoza; C J Ocampo; M Saura; A McMillan; C J Lowenstein
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus.

Authors:  T E Lane; A D Paoletti; M J Buchmeier
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 3.  Does nitric oxide play a critical role in viral infections?

Authors:  C S Reiss; T Komatsu
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 4.  Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity.

Authors:  F C Fang
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

5.  The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis.

Authors:  C Zaragoza; C Ocampo; M Saura; M Leppo; X Q Wei; R Quick; S Moncada; F Y Liew; C J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

6.  Nitric oxide inhibits HIV tat-induced NF-kappaB activation.

Authors:  F Chen; Y Lu; V Castranova; Y Rojanasakul; K Miyahara; Y Shizuta; V Vallyathan; X Shi; L M Demers
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

7.  A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo.

Authors:  M S Rolph; W B Cowden; C J Medveczky; I A Ramshaw
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages.

Authors:  D Blond; H Raoul; R Le Grand; D Dormont
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

Authors:  D F Stojdl; N Abraham; S Knowles; R Marius; A Brasey; B D Lichty; E G Brown; N Sonenberg; J C Bell
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

10.  CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.

Authors:  John Goulding; Georges Abboud; Vikas Tahiliani; Pritesh Desai; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2014-04-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.